SpaceX is pricing at a $2.1 trillion valuation, which Morningstar and other commentators call aggressive, though the company disclosed $11.4 billion of 2025 Connectivity revenue, $7.17 billion of segment adjusted EBITDA, and roughly $26 billion of new annual revenue from Anthropic and Google partnerships. The article emphasizes retail demand, with 20% to 30% of IPO shares reportedly allocated to retail, while also flagging dilution and execution risk from xAI’s $6.35 billion operating loss on $3.2 billion of revenue and $7.7 billion of AI capex in Q1 2026. Rocket Lab is presented as a public-market proxy, with Q1 revenue of $200.35 million, up 63.46% year over year, and a $2.20 billion backlog.
The clearest winner is not the IPO itself but the adjacent public proxies that give investors a way to own the “space stack” without paying the private-market scarcity premium. That favors the best-capitalized launch/space infrastructure names less for near-term fundamentals and more because retail will need a liquid substitute once the initial allocation lottery closes; this tends to create a multi-week to multi-month sympathy bid in the most obvious proxy names.
The bigger second-order effect is on Google, not because the partnership revenue is the main driver, but because it reinforces the market’s willingness to underwrite frontier AI infrastructure with customer concentration and power-hungry capex as long as there is a credible demand anchor. That can support multiple expansion for hyperscale-adjacent infrastructure owners in the short run, but it also raises the bar for any company selling “AI capacity” without visible monetization. The market is implicitly saying cash burn is acceptable only when paired with a brand-name distribution channel or strategic moat.
The contrarian setup is that the deal’s scarcity and retail enthusiasm may compress forward returns more than the business quality justifies. When a large fraction of supply is locked up in a highly emotional retail book, the first real catalyst may be lock-up expiry rather than operating milestones; that often creates a second entry point 3-9 months later when early holders monetize and the narrative resets. In other words, the risk is not just a bad quarter, but a long period where every operational miss is amplified by valuation fatigue.
For Rocket Lab, the trade works only if the market keeps treating it as the closest public substitute for a private asset it cannot own. That proxy premium is vulnerable if execution slips on the next major product milestone or if the IPO’s aftermarket weakens, because the relative valuation argument is almost entirely flow-driven rather than fundamental. If retail enthusiasm cools, the proxy trade can unwind faster than the underlying business changes.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.15
Ticker Sentiment